Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
PT Asuransi Maximus Graha Persada Tbk (ASMI.JK)
Jakarta Utara, ID
PT Asuransi Maximus Graha Persada Tbk is an Indonesian firm engaged in the provision of comprehensive general insurance and reinsurance solutions. Its diverse portfolio of offerings encompasses essential coverage for sectors like automotive, property (fire), health, marine cargo, monetary assets, and engineering projects. Additionally, the company provides sharia-compliant insurance products. Beyond these core areas, it extends a wide array of specialized policies, including protection against burglary, earthquake damage, personal accidents, movable property risks, workers' compensation, comprehensive general liability, product and public liability, professional indemnity, employers' liability, and surety bonds. Established in 1956, the company maintains its principal office in Jakarta Utara, Indonesia.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -5.56% | +0.00% | -10.53% | -46.88% | -39.29% | -43.33% | -5.56% | -66.00% | -97.54% | -94.53% | -79.01% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Insurance - Diversified: +15.2%-2.3% Q3'25: +42.7% (vs Q3'24)
-
EPS growth Insurance - Diversified: +25.3%-6.0% Q3'25: +114.5% (vs Q3'24)
-
FCF margin FCF growth · Insurance - Diversified: +30.2%+2.5% Q3'25: -12.7% (vs Q3'24)
-
EBIT margin Insurance - Diversified: +13.5%+2.4% Q3'25: +2.0% (vs Q3'24)
-
ROIC Insurance - Diversified: +4.2%+2.2% Q3'25: +3.8% (vs Q3'24)
-
Share dilution Insurance - Diversified: +0.0%+0.0% Q3'25: +0.0% (vs Q3'24)
-
Debt / EBITDA Net debt/EBITDA · Insurance - Diversified: -0.05×0.22× ★ Q3'25: 0.01× (vs Q3'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B | 3/5 | 1/5 | 3/5 | 4/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-26 | B | 3/5 | 1/5 | 3/5 | 4/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-25 | B | 3/5 | 1/5 | 3/5 | 4/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-22 | B | 3/5 | 1/5 | 3/5 | 4/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-21 | B | 3/5 | 1/5 | 3/5 | 4/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-20 | B | 3/5 | 1/5 | 3/5 | 4/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-19 | B | 3/5 | 1/5 | 3/5 | 4/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-18 | B | 3/5 | 1/5 | 3/5 | 4/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-13 | B | 3/5 | 1/5 | 2/5 | 4/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-12 | B | 3/5 | 1/5 | 2/5 | 4/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-11 | B | 3/5 | 1/5 | 2/5 | 4/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-08 | B | 3/5 | 1/5 | 2/5 | 4/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-07 | B | 3/5 | 1/5 | 2/5 | 4/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-06 | B | 3/5 | 1/5 | 2/5 | 4/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-05 | B | 3/5 | 1/5 | 2/5 | 5/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-04 | B | 3/5 | 1/5 | 2/5 | 5/5 | 4/5 | 2/5 | 3/5 |
| 2026-04-30 | B | 3/5 | 1/5 | 2/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-04-29 | B | 3/5 | 1/5 | 3/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-04-28 | B | 3/5 | 1/5 | 3/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-04-27 | B | 3/5 | 1/5 | 3/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-04-24 | B | 3/5 | 1/5 | 3/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-04-23 | B | 3/5 | 1/5 | 3/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-04-22 | B | 3/5 | 1/5 | 3/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-04-21 | B+ | 3/5 | 1/5 | 3/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-04-20 | B+ | 3/5 | 1/5 | 3/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-04-17 | B | 3/5 | 1/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-16 | B | 3/5 | 1/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Agus Mulyadi | Chairman of the Internal Audit Unit & Internal Audit Manager | — | male |
| Jemmy Atmadja | President Director | — | male |
| Lucas Salam | Head of Information Technology | — | — |
| Nadia Wahadaniah | Head of Finance & Accounting | — | female |
| Norvin Osel | Director & Corporate Secretary | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ASMI.JK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
